Program to Improve Prescribing of Primarily Renally Cleared Oral Medications in Older Veteran Community Living Center Patients

Article Type
Article
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Program to Improve Prescribing of Primarily Renally Cleared Oral Medications in Older Veteran Community Living Center Patients
Author(s)
Hanlon J
Handler SM
Aspinall SL

Article PDF
027100034.pdf
Author and Disclosure Information

Joseph Hanlon, PharmD, MS; Steven M. Handler, MD, PhD; and Sherrie L. Aspinall, PharmD, MSc

Dr. Hanlon is a health scientist with the Geriatric Research, Education and Clinical Center (GRECC), VA Pittsburgh Healthcare System (VAPHS) in Pennsylvania and a professor in the Department of Medicine (Division of Geriatric Medicine), the Department of Epidemiology, and the Department of Pharmacy and Therapeutics at the University of Pittsburgh (UPitt) in Pennsylvania. Dr. Handler is a health scientist with the VAPHS GRECC and is an assistant professor in the Department of Medicine (Division of Geriatric Medicine) and the Department of Biomedical Informatics at UPitt. Dr. Aspinall is a health scientist with the VA Center for Medication Safety in Hines, Illinois, and is an associate professor in the Department of Pharmacy and Therapeutics at UPitt. Drs. Hanlon, Handler, and Aspinall also are all health scientists at the VAPHS Center for Health Equity Research and Promotion.

Issue
Federal Practitioner - 27(10)
Publications
Federal Practitioner
Topics
Nephrology
Page Number
34
Legacy Keywords
renal disease, primarily renally cleared oral medications, pharmacotherapy, community living center, adverse drug reactions, digoxin, glyburide, spirononolactone, Geriatric Research, Education and Clinical Center, dosing recommendations, creatinine clearance, quality improvementrenal disease, primarily renally cleared oral medications, pharmacotherapy, community living center, adverse drug reactions, digoxin, glyburide, spirononolactone, Geriatric Research, Education and Clinical Center, dosing recommendations, creatinine clearance, quality improvement
Sections
Best Practices
Author(s)
Hanlon J
Handler SM
Aspinall SL
Author(s)
Hanlon J
Handler SM
Aspinall SL
Author and Disclosure Information

Joseph Hanlon, PharmD, MS; Steven M. Handler, MD, PhD; and Sherrie L. Aspinall, PharmD, MSc

Dr. Hanlon is a health scientist with the Geriatric Research, Education and Clinical Center (GRECC), VA Pittsburgh Healthcare System (VAPHS) in Pennsylvania and a professor in the Department of Medicine (Division of Geriatric Medicine), the Department of Epidemiology, and the Department of Pharmacy and Therapeutics at the University of Pittsburgh (UPitt) in Pennsylvania. Dr. Handler is a health scientist with the VAPHS GRECC and is an assistant professor in the Department of Medicine (Division of Geriatric Medicine) and the Department of Biomedical Informatics at UPitt. Dr. Aspinall is a health scientist with the VA Center for Medication Safety in Hines, Illinois, and is an associate professor in the Department of Pharmacy and Therapeutics at UPitt. Drs. Hanlon, Handler, and Aspinall also are all health scientists at the VAPHS Center for Health Equity Research and Promotion.

Author and Disclosure Information

Joseph Hanlon, PharmD, MS; Steven M. Handler, MD, PhD; and Sherrie L. Aspinall, PharmD, MSc

Dr. Hanlon is a health scientist with the Geriatric Research, Education and Clinical Center (GRECC), VA Pittsburgh Healthcare System (VAPHS) in Pennsylvania and a professor in the Department of Medicine (Division of Geriatric Medicine), the Department of Epidemiology, and the Department of Pharmacy and Therapeutics at the University of Pittsburgh (UPitt) in Pennsylvania. Dr. Handler is a health scientist with the VAPHS GRECC and is an assistant professor in the Department of Medicine (Division of Geriatric Medicine) and the Department of Biomedical Informatics at UPitt. Dr. Aspinall is a health scientist with the VA Center for Medication Safety in Hines, Illinois, and is an associate professor in the Department of Pharmacy and Therapeutics at UPitt. Drs. Hanlon, Handler, and Aspinall also are all health scientists at the VAPHS Center for Health Equity Research and Promotion.

Article PDF
027100034.pdf
Article PDF
027100034.pdf

Issue
Federal Practitioner - 27(10)
Issue
Federal Practitioner - 27(10)
Page Number
34
Page Number
34
Publications
Federal Practitioner
Publications
Federal Practitioner
Topics
Nephrology
Article Type
Article
Display Headline
Program to Improve Prescribing of Primarily Renally Cleared Oral Medications in Older Veteran Community Living Center Patients
Display Headline
Program to Improve Prescribing of Primarily Renally Cleared Oral Medications in Older Veteran Community Living Center Patients
Legacy Keywords
renal disease, primarily renally cleared oral medications, pharmacotherapy, community living center, adverse drug reactions, digoxin, glyburide, spirononolactone, Geriatric Research, Education and Clinical Center, dosing recommendations, creatinine clearance, quality improvementrenal disease, primarily renally cleared oral medications, pharmacotherapy, community living center, adverse drug reactions, digoxin, glyburide, spirononolactone, Geriatric Research, Education and Clinical Center, dosing recommendations, creatinine clearance, quality improvement
Legacy Keywords
renal disease, primarily renally cleared oral medications, pharmacotherapy, community living center, adverse drug reactions, digoxin, glyburide, spirononolactone, Geriatric Research, Education and Clinical Center, dosing recommendations, creatinine clearance, quality improvementrenal disease, primarily renally cleared oral medications, pharmacotherapy, community living center, adverse drug reactions, digoxin, glyburide, spirononolactone, Geriatric Research, Education and Clinical Center, dosing recommendations, creatinine clearance, quality improvement
Sections
Best Practices
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Aspinall SL